Skip to main content
. 2020 Sep 25;10:15820. doi: 10.1038/s41598-020-72810-0

Table 3.

Multivariate survival analysis.

HR (95% CI) P-value
Cancer-specific survivala
Methylation status of the eight methylation markers
 Low methylation 149 Ref
 High methylation 23 0.30 (0.09–0.97) 0.040
Recurrence-free survivala
Methylation status of the eight methylation markers
 Low methylation 149 Ref
 High methylation 23 0.35 (0.17–0.72) 0.005

aAdjusted for gross type, histological type, differentiation grade, lymphatic emboli, venous invasion, perineural invasion, T stage, N stage, M stage, and IDH1/2 mutation status.